5 intersections of GLP-1s and digital health Personalized medicine: Data integration: Digital health tools can collect data from patients using GLP-1 agonists, including blood glucose levels, weight, and activity patterns
This method ensures faster and more potent results compared to oral supplements
Most patients do not experience dramatic effects on day one, though some notice subtle appetite shifts by day 2-3
Jrgensen, M
No images due to patient privacy
Of note is that the observed median time to onset of the psychiatric AEs in our analysis of the FAERS data aligned with common gastrointestinal AEs such as nausea and vomiting, which were the most frequently reported within the first 30 days of GLP-1 RA treatment ( In this extensive pharmacovigilance study, we observed a significant association between GLP-1 RAs and eight distinct categories of psychiatric AEs, namely, nervousness, stress, eating disorder, fear of injection, sleep disorder due to general medical conditioninsomnia type, binge eating, fear of eating, and self-induced vomiting